AGTC Announces Significant Productivity and Quality Enhancement to Its Proprietary Manufacturing Process
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials... Read More
Morphogenesis Seeks Skin Cancer Patients for New Clinical Trials
Known for developing personalized immunotherapies for the treatment of cancer through novel cell and gene therapies, UF startup and UF Innovate |... Read More
AGTC Launches Nationwide Mobile Vision Testing Program for Patients Enrolled in Its Ongoing Phase 1/2 Clinical Trials
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials... Read More
Pheronym Wins $225,000 NSF Grant for Commercializing Nematode Pheromones for Eco-Friendly Pest Control in Agriculture
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, a bio-ag-tech pest control company, has received a... Read More
Professor at UF Veterinary College Honored by National Veterinary Microbiology Group
Roy Curtiss III, Ph.D., a professor at the University of Florida College of Veterinary Medicine, has received the 2020 Distinguished Veterinary Microbiologist... Read More
Pheronym Receives Grant to Achieve Commercialization Milestones
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an ag-biotech pest control company, received a $25,000 grant from Agstart to... Read More
TearClear Appoints Dr. Amir Shojaei Chief Development Officer
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, a global ophthalmic pharmaceutical company, has announced the appointment of... Read More
ImmuneFX Gene Therapy Could Be a Game-Changer for Cancer Treatment
UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., a clinical-stage company that develops novel cell and gene therapies... Read More
After Acquisition, Tampa Biotech Firm Looks Toward COVID-19 Vaccine
Serendipity is the word Alan Joslyn uses to describe the meeting and eventual acquisition of a Gainesville-based biotech firm. “It’s not every... Read More
Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against... Read More
